No Data
Express News | Emergent BioSolutions Appoints DR. Simon Lowry as Chief Medical Officer and Head of Research and Development
Press Release: Emergent BioSolutions Appoints Dr. Simon Lowry as Chief Medical Officer and Head of Research and Development
Earnings Preview: EBS to Report Financial Results Post-market on November 06
$Emergent BioSolutions(EBS.US)$ is scheduled to release its financial results post-market on November 06 ET. Earnings PreviewAnalysts estimate $Emergent BioSolutions(EBS.US)$ to post revenue of USD297
First Mpox Case Linked to African Outbreak Reported in U.K.
WHO Expands Emergency Use List For Mpox Diagnostics, Adds Cepheid's Xpert Mpox PCR Test And Roche's Cobas MPXV Assay As PCR-Based Gold Standard Options
Emergent BioSolutions to Release Third Quarter 2024 Financial Results and Conduct Conference Call on November 6, 2024